RCYC
AVNS

Richard C. Young & Co’s Avanos Medical AVNS Stock Holding History

Richard C. Young & Co’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,540
Closed -$224K – 73
2015
Q2 		$224K Sell
5,540
-1,232
-18% -$55.3K 0.05% 71
2015
Q1 		$333K Sell
6,772
-271
-4% -$12.6K 0.07% 64
2014
Q4 		$320K Buy
+7,043
New +$277K 0.07% 74

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Richard C. Young & Co's AVNS Position: Q3 2015 in Review

Richard C. Young & Co sold out of Avanos Medical (AVNS) in Q3 2015, closing a stake of 5,540 shares — an estimated $224K sold.

Richard C. Young & Co first reported a position in AVNS in Q4 2014 and held it in 3 quarters. The position peaked at $333K in Q1 2015. 353 funds tracked by Wall St. Rank hold AVNS as of Q3 2015.

  • Richard C. Young & Co reported no remaining Avanos Medical position as of Q3 2015 after selling out during the quarter.
  • Richard C. Young & Co sold 5,540 Avanos Medical shares in Q3 2015, an estimated $224K.
  • Richard C. Young & Co first reported a position in Avanos Medical in Q4 2014 and held it in 3 quarters.
  • Richard C. Young & Co's Avanos Medical position peaked at $333K in Q1 2015.
  • 353 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2015.

Based on Richard C. Young & Co's 13F filing for Q3 2015, filed 10 Nov 2015.